Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04705766 · ClinicalTrials.gov registry record
KIDney Injury in Times of COVID-19 (KIDCOV)
A clinical trial of COVID-19 and Acute Kidney Injury, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- 2,000
- Enrollment target
- 3
- Study locations
NCT04705766: Recruiting study of COVID-19 and Acute Kidney Injury, sponsored by University of California, San Francisco.
NCT04705766 is a study of COVID-19 and Acute Kidney Injury that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 2,000 participants, below the 38,458-participant average among 298 other COVID-19 trials with a reported enrollment target (95% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04705766, a study of COVID-19 and Acute Kidney Injury, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 3
- Study locations
Study Summary
There is an unmet need to evaluate the impact of sub-clinical/mild COVID19 disease in the outpatient setting on prevalent and incident renal injury, as this data is currently unavailable. To capture the diversity of race/ethnic risk and COVID19 related municipal shelter-in-place guidance, the investigators will enroll COVID19-negative and COVID19-positive samples balanced by race/ethnicity from 3 different states, California, Michigan, and Illinois. Study endpoints will be assayed from urine samples mailed to the study team at 2, 6, and 12 months after their date of PCR test, with no requirement for these individuals to leave their homes to participate.
Primary Outcome
The 12-month continuous, quantitative Kidney Injury Test (KIT) score, measured on a scale of 0-100, where a higher urine-based KIT score correlates to worse kidney injury.
Conditions Studied
Interventions
- OTHER Urine Collection
Study Locations (3)
California
- UCSF - San Francisco
Illinois
- Rush University - Chicago
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2021-03-01 |
| Est. Completion | 2027-03 |
What NCT04705766 shows while recruiting
NCT04705766 is an observational study that tracks outcomes without assigning an intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus, below the 38,458-participant average among 298 other COVID-19 trials with a reported enrollment target (95% lower).
The record links to 5 conditions, with COVID-19 appearing as the primary indexed condition, and to 1 intervention - of which Urine Collection is the first listed.
NCT04705766 reports a single indexed study location in California, Illinois, Michigan.
Frequently Asked Questions
What is clinical trial NCT04705766 about?
NCT04705766 is a clinical study titled "KIDney Injury in Times of COVID-19 (KIDCOV)". There is an unmet need to evaluate the impact of sub-clinical/mild COVID19 disease in the outpatient setting on prevalent and incident renal injury, as this data is currently unavailable. To capture the diversity of race/ethnic risk and COVID19 related municipal shelter-in-place guidance, the invest...
What is the current status of trial NCT04705766?
This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2021-03-01. Estimated completion is 2027-03.
What conditions does trial NCT04705766 study?
This clinical trial studies the following conditions: COVID-19, Acute Kidney Injury, Corona Virus Infection, SARS-CoV Infection, Kidney Injury.
What interventions are being tested in trial NCT04705766?
The interventions under investigation include: Urine Collection (OTHER).
Who is sponsoring clinical trial NCT04705766?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04705766 being conducted?
This trial has 3 study locations across California, Illinois, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COVID-19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04705766's enrollment target sits among peer trials
2,000 44th of 298 higher than 254 of 298 other COVID-19 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other COVID-19 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
RECRUITING · NA
-
Arginine Replacement Therapy in COVID-19
RECRUITING · Phase 2
-
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children
RECRUITING · Phase 2
-
Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors
RECRUITING
-
COVID-19 Health Adjustments in Nutrition, General Wellness, and Exercise
RECRUITING
-
The Impact of COVID-19 on Maternal and Neonatal Outcomes
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
- NCT00001595 · 2,000 participants
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
- NCT00138931 · 2,000 participants
Genetics of Cardiovascular and Neuromuscular Disease
- NCT00288119 · 2,000 participants
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI